Global Vibrating Mesh Nebulizer Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 386.91 Million |
| Market Size (2029) | USD 599.01 Million |
| CAGR (2024 - 2029) | 9.13 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Global Vibrating Mesh Nebulizer Market Analysis
The Global Vibrating Mesh Nebulizer Market size is estimated at USD 386.91 million in 2024, and is expected to reach USD 599.01 million by 2029, growing at a CAGR of 9.13% during the forecast period (2024-2029).
Factors such as the increasing prevalence of chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma, along with the growing demand for nebulizer devices, are expected to drive market growth. In addition, advancements in nebulization technology and the growing introduction of new mesh nebulizers are expected to fuel market expansion.
The high burden of respiratory conditions is expected to fuel market growth during the study period. For instance, according to June 2024 data from the Australian Institute of Health and Welfare, asthma is common in Australia. It affected around 2.8 million people in 2022. Additionally, as per the same source, asthma accounted for 2.5% of the overall disease burden in the country. Therefore, such a significant disease burden is projected to accelerate market expansion during the study period.
Additionally, according to November 2023 data from the World Health Organization (WHO), the burden of COPD has increased significantly over the years in China. In 2023, the country had around 100 million people living with COPD and accounted for almost 25% of all COPD cases globally. Hence, the high burden of respiratory conditions is one of the key factors contributing to the significant demand for vibrating mesh nebulizers, as vibrating mesh nebulizers offer efficient and targeted delivery of medication directly to the lungs due to their vibrating aerosol technology.
In addition, the enhanced dose delivery with the help of a vibrating mesh nebulizer and its efficiency in pulmonary dose delivery is expected to propel its adoption during the study period. Moreover, multiple articles have emphasized the optimization of dose delivery using vibrating mesh nebulizers. These characteristics associated with vibrating mesh nebulizers are expected to increase adoption rates.
For instance, an article published by Atmosphere in September 2023 demonstrated that optimizing the air inlet structures of vibrating mesh nebulizers (VMNs) is critical for enhancing the efficiency of pulmonary drug delivery. The article also highlighted the importance of air inlet structures for the future designs and development of vibrating mesh nebulizers. Therefore, such instances are expected to offer growth momentum for the market over the coming years.
Also, several benefits associated with vibrating mesh nebulizers over other types of nebulizers are projected to uphold their adoption rate during the study period. According to an article published in Frontiers in Drug Delivery in October 2022, vibrating mesh nebulizers have improved the ability to administer medical aerosols to small children and infants using nasal cannula. Additionally, their ability to deliver medication without the need for compressed gas has increased their use in medical settings.
Therefore, such great benefits associated with vibrating mesh nebulizers are projected to promote utilization over the coming years. Hence, all the above factors are expected to drive market growth over the coming years.
However, the stringent regulatory framework and high cost of devices are anticipated to hinder market growth during the forecast period.
Global Vibrating Mesh Nebulizer Market Trends
The COPD Segment is Expected to Witness Considerable Growth During the Forecast Period
The COPD segment is expected to exhibit a significant growth rate during the study period owing to factors such as the growing burden of COPD globally, coupled with increasing utilization of vibrating mesh nebulizers to deliver targeted therapies in COPD. Moreover, supportive government initiatives promoting awareness about COPD are expected to drive demand for respiratory devices such as vibrating mesh nebulizers, fueling market uptake.
The alarming burden of COPD is expected to fuel the adoption of vibrating mesh nebulizers to deliver targeted treatment regimens to restore damaged lung functions. For instance, according to August 2024 data from the American Lung Association, around 11.7 million, or 4.6% of adults in the United States, suffered from COPD or any of its forms in 2022. Hence, the significant burden of COPD is expected to foster market expansion over the coming years.
The segment growth is expected to be driven by the adoption of vibrating mesh nebulizers compared to jet nebulizers in treating chronic obstructive pulmonary disease. For instance, according to an article published by the International Journal of Chronic Obstructive Pulmonary Disease in March 2024, vibrating mesh nebulizers have significant drug delivery capabilities for COPD compared to jet nebulizers, and this capability has remarkably improved their adoption in the treatment of COPD. Therefore, such proven benefits of vibrating mesh nebulizers are projected to bolster their uptake, thereby driving segment expansion.
Additionally, the utilization of vibrating mesh nebulizers to deliver different classes of bronchodilators in COPD management has opened new business avenues for market uptake. For instance, in October 2022, HCmed and AeroRx used the breath-actuated nebulizer (vibrating mesh) to deliver pulmonary drugs for COPD as these nebulizers deliver doses of medicines in the form of mist when the patient inhales. Hence, such instances are anticipated to generate new business opportunities for segment expansion.
Also, the growing research funding for COPD is expected to accelerate demand for advanced respiratory devices, fueling market expansion. For example, 2024 data from the National Institute of Health shows that research funding for COPD is projected to increase to 149 million from 148 million in 2023. Hence, increasing research funding is expected to bolster industry growth over the coming years.
Therefore, the factors mentioned above, such as the growing burden of COPD and the utilization of vibrating mesh nebulizers in COPD, are expected to drive segment market growth.
North America is Expected to Witness Considerable Growth During the Forecast Period
North America is expected to hold a significant market share in the vibrating mesh nebulizer market due to factors such as the increasing prevalence of respiratory disorders in the region and the growing adoption of technologically advanced nebulizers. In addition, growing awareness for vibrating mesh nebulizers in home care settings is projected to support regional market growth over the coming years.
The growing burden of asthma in North America is expected to support market growth. For instance, according to data published by the Asthma and Allergy Foundation of America in September 2023, more than 27 million people in the United States had asthma. In addition, around 10.8% of female adults had asthma, compared to 6.5% of male adults in 2023. Therefore, the significant burden of respiratory disease in North America is expected to bolster market expansion during the study period.
Also, supportive reimbursement policies for respiratory devices, mainly vibrating mesh nebulizers, are anticipated to create significant opportunities in the market. For example, data from the United States Centers for Medicare & Medicaid Services in January 2024, nebulizers, including vibrating mesh models, are covered under the Durable Medical Equipment (DME) benefit. These favorable reimbursement policies are projected to enhance product utilization, supporting industry growth.
Moreover, supportive reimbursement policies for respiratory devices, including vibrating mesh nebulizers, are projected to offer potential opportunities in the market. For instance, according to January 2024 data from the United States Centers for Medicare & Medicaid Services, nebulizers, including vibrating mesh nebulizers, are covered under its Durable Medical Equipment (DME) benefit. Hence, the supportive reimbursement policies are expected to accelerate the utilization of these products, thereby driving regional market growth.
Additionally, ongoing investigational studies using vibrating mesh nebulizers in the United States are expected to boost regional market expansion. For instance, according to September 2024 data from ClinicalTrial.Gov, four active studies are investigating the administration of lung therapeutics through vibrating mesh nebulizer delivery. Hence, such ongoing investigational studies will drive regional market growth during the study period.
Hence, the above factors are expected to drive the North American market during the forecast period.
Global Vibrating Mesh Nebulizer Industry Overview
The vibrating mesh nebulizer market is fragmented and has several significant players. Key players in this market are implementing various organic and inorganic strategies to strengthen their revenue shares. Some companies dominating the market are Aerogen Ltd, BPL Medical Technologies, Hamilton Medical AG, Koninklijke Philips NV, and Odin Healthcare Pvt. Ltd, OMRON Healthcare Inc., PARI GmbH, Phoenix Healthcare Solutions LLC, Timago International Group, and Vectura Group Ltd.
Global Vibrating Mesh Nebulizer Market Leaders
-
OMRON Healthcare, Inc
-
BPL Medical Technologies
-
Hamilton Medical.
-
PARI GmbH
-
Koninklijke Philips NV
*Disclaimer: Major Players sorted in no particular order
Global Vibrating Mesh Nebulizer Market News
- March 2024: HCmed received approval from the United States Food and Drug Administration for its Pulmogine Vibrating Mesh Nebulizer. This product is one of the approved devices that can be used to deliver cystic fibrosis medicine Pulmozyme.
- April 2023: The US-based medical device manufacturer ABM Respiratory Care unveiled BiWaze Clear, an advanced airway clearance system. Designed to assist patients with acute and chronic respiratory issues, BiWaze Clear aids in lung clearance in hospitals, post-acute facilities, and home care settings. A fully enclosed, disposable dual-lumen breathing circuit was central to its design, complemented by a closed, vibrating mesh nebulizer. This combination aided in aerosol therapy and targeted airway inflammation and mucus thinning.
Global Vibrating Mesh Nebulizer Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Respiratory Disorders
4.2.2 Advancements in Nebulizer Technology
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Type
5.1.1 Active Mesh Nebulizer
5.1.2 Passive Mesh Nebulizer
5.2 By Age Group
5.2.1 Adults
5.2.2 Pediatric
5.3 By Application
5.3.1 Asthma
5.3.2 COPD
5.3.3 Cystic Fibrosis
5.3.4 Other Applications
5.4 By End User
5.4.1 Hospital and Clinics
5.4.2 Emergency Centers
5.4.3 Home Care
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aerogen Ltd
6.1.2 BPL Medical Technologies
6.1.3 Hamilton Medical AG
6.1.4 Koninklijke Philips NV
6.1.5 Odin Healthcare Pvt. Ltd
6.1.6 OMRON Healthcare Inc.
6.1.7 PARI GmbH
6.1.8 Phoenix Healthcare Solutions LLC
6.1.9 Timago International Group
6.1.10 Vectura Group Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Global Vibrating Mesh Nebulizer Industry Segmentation
As per the scope of the report, a vibrating mesh nebulizer is a medical device that utilizes a mesh membrane with tiny holes to aerosolize liquid medication into fine mist particles for inhalation. This technology allows for efficient and targeted delivery of respiratory treatments, enhancing patient comfort and compliance.
The market is segmented by type, age group, application, and end user. Based on type, the market is segmented as active mesh nebulizers and passive mesh nebulizers. Based on age group, the market is segmented into adults and pediatric. Based on application, the market is segmented into COPD, asthma, cystic fibrosis, and other applications. Further, based on end users, the market is segmented as hospitals and clinics, emergency centers, and home care. By geography, the market is segmented as North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the market sizes and forecasts for the vibrating mesh nebulizer market in major countries across different regions. For each segment, the report offers market size and forecasts in terms of value (USD).
| By Type | |
| Active Mesh Nebulizer | |
| Passive Mesh Nebulizer |
| By Age Group | |
| Adults | |
| Pediatric |
| By Application | |
| Asthma | |
| COPD | |
| Cystic Fibrosis | |
| Other Applications |
| By End User | |
| Hospital and Clinics | |
| Emergency Centers | |
| Home Care |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Vibrating Mesh Nebulizer Market Research FAQs
How big is the Global Vibrating Mesh Nebulizer Market?
The Global Vibrating Mesh Nebulizer Market size is expected to reach USD 386.91 million in 2024 and grow at a CAGR of 9.13% to reach USD 599.01 million by 2029.
What is the current Global Vibrating Mesh Nebulizer Market size?
In 2024, the Global Vibrating Mesh Nebulizer Market size is expected to reach USD 386.91 million.
Who are the key players in Global Vibrating Mesh Nebulizer Market?
OMRON Healthcare, Inc, BPL Medical Technologies, Hamilton Medical., PARI GmbH and Koninklijke Philips NV are the major companies operating in the Global Vibrating Mesh Nebulizer Market.
Which is the fastest growing region in Global Vibrating Mesh Nebulizer Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Vibrating Mesh Nebulizer Market?
In 2024, the North America accounts for the largest market share in Global Vibrating Mesh Nebulizer Market.
What years does this Global Vibrating Mesh Nebulizer Market cover, and what was the market size in 2023?
In 2023, the Global Vibrating Mesh Nebulizer Market size was estimated at USD 351.59 million. The report covers the Global Vibrating Mesh Nebulizer Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Vibrating Mesh Nebulizer Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Vibrating Mesh Nebulizer Industry Report
Statistics for the 2024 Global Vibrating Mesh Nebulizer market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Vibrating Mesh Nebulizer analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
